Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.
about
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunitiesThe reversal of multidrug resistance: an update.Preparation of magnetic polybutylcyanoacrylate nanospheres encapsulated with aclacinomycin A and its effect on gastric tumorTargeted drug delivery in cancer therapy.Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles.Nanotechnology for targeted cancer therapy.Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery.Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.Nanovehicular intracellular delivery systems.Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug.Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.Nanocarriers' entry into the cell: relevance to drug delivery.Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.Cellular uptake of nanoparticles: journey inside the cell.Cationic nanoparticles for delivery of amphotericin B: preparation, characterization and activity in vitro.Ketoprofen-loaded polymeric nanocapsules selectively inhibit cancer cell growth in vitro and in preclinical model of glioblastoma multiforme.Reversal of multidrug resistance by magnetic chitosan-Fe₃O₄ nanoparticle-encapsulated MDR₁ siRNA in glioblastoma cell line.Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer.Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin.Evaluating the potential of polymer nanoparticles for oral delivery of paclitaxel in drug-resistant cancer.Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells.Polyanionic carbohydrate doxorubicin-dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations.Study on the role of 5-fluorouracil in the polymerization of butylcyanoacrylate during the formation of nanoparticles.Patrick Couvreur: inspiring pharmaceutical innovation.Phytochemical based nanomedicines against cancer: current status and future prospects.Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma.Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma.
P2860
Q26828930-0C096B7F-4417-4A04-9CAB-CC6C088CA008Q35118813-13499EDF-F0AB-421D-94BF-309FB38569DCQ36066170-7D57C885-4F93-4518-9F83-3863BF138E30Q36200150-962CCA5A-BAE9-4668-B495-C0BDE65BED50Q36443038-CC839BAC-57C8-47D9-A4F1-CC763E4983BEQ36842770-E2A3E5BB-B698-49C9-8EDA-95EDB58D6D7DQ37015849-BC353683-C54D-41AC-83E0-5CE764058F2AQ37031597-2D3CF12A-C365-444F-96B2-4749EFF00533Q37058812-0220BAFC-6D85-450A-8C3E-0F5DCA77DA3EQ37076372-573A9983-8066-4CEA-B45C-BB41F6E5227BQ37378180-67BB9190-3252-4CA7-B3A6-F53EFECA7542Q37438909-436656C4-5E8B-4364-AE21-B3E4749A8BF2Q37508725-4AF46E3C-6F8E-41DC-8A58-AAD109AC08DBQ37763152-DDC408BD-BB0D-4C30-90C3-B6B8CE05F807Q38289271-55FE9019-A3ED-48D6-8093-4DF1FEB39F82Q38557482-02FABCFD-56B5-4547-8B4E-F2AFBBA770C3Q38787429-D42228F8-1FB9-4245-8467-8A23E5EAD0D3Q39090751-ED874B1D-89ED-41E4-83F8-D56AF51B8EF4Q39155106-87C273BD-8A37-435F-B587-5BF2A3C48827Q39616068-0011B95A-CA2D-40C5-86B9-417D8CF9B74EQ39711516-B24ADAAF-6590-438C-9718-3382580F6CC6Q39757347-B5249C64-9F80-4997-8F2E-2348BCAD5865Q39925586-FBF3B169-6AA1-4350-AE96-63C80471CB9AQ40265140-53A2CE3F-EE29-4E63-B9A0-7454A83D030CQ42033682-53CD186E-456A-4F78-8FA9-81B49F750D82Q44941786-2CC89FEF-256E-4814-BD0D-921FE321DCDEQ45345029-60EF15B3-09DF-4B26-AAD9-3662D2F4B58FQ47829215-8FE824B1-2650-4F39-8498-2A1CD2F347AEQ55266511-42E75874-A06D-4D9E-B404-A32BAFD0DB74Q55461261-B93613F9-EDB8-4F2C-8F7B-C2120DD96860
P2860
Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Reversion of multidrug resista ...... towards a mechanism of action.
@en
type
label
Reversion of multidrug resista ...... towards a mechanism of action.
@en
prefLabel
Reversion of multidrug resista ...... towards a mechanism of action.
@en
P2093
P2860
P356
P1476
Reversion of multidrug resista ...... towards a mechanism of action.
@en
P2093
Dubernet C
Puisieux F
de Verdière AC
P2860
P2888
P304
P356
10.1038/BJC.1997.362
P407
P577
1997-01-01T00:00:00Z